Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene.

Otten R, Engels RC.

Addict Biol. 2013 Sep;18(5):826-35. doi: 10.1111/j.1369-1600.2011.00380.x. Epub 2011 Oct 4.

PMID:
21967091
2.

Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study.

Ming QS, Zhang Y, Chai QL, Chen HY, Hou CJ, Wang MC, Wang YP, Cai L, Zhu XZ, Yi JY, Yao SQ.

BMC Psychiatry. 2013 May 17;13:142. doi: 10.1186/1471-244X-13-142.

3.

The association of 5-HTTLPR genotype and depressive symptoms is moderated by physical activity.

Rethorst CD, Landers DM, Nagoshi CT, Ross JT.

J Psychiatr Res. 2011 Feb;45(2):185-9. doi: 10.1016/j.jpsychires.2010.05.007. Epub 2010 Jun 9.

PMID:
20538286
4.

5-HTTLPR X stress in adolescent depression: moderation by MAOA and gender.

Priess-Groben HA, Hyde JS.

J Abnorm Child Psychol. 2013 Feb;41(2):281-94. doi: 10.1007/s10802-012-9672-1.

PMID:
22836288
5.

Serotonin transporter-linked polymorphic region (5-HTTLPR) genotype and stressful life events interact to predict preschool-onset depression: a replication and developmental extension.

Bogdan R, Agrawal A, Gaffrey MS, Tillman R, Luby JL.

J Child Psychol Psychiatry. 2014 May;55(5):448-57. doi: 10.1111/jcpp.12142. Epub 2013 Oct 4.

6.

Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene.

Otten R, Huizink AC, Monshouwer K, Creemers HE, Onrust S.

Addict Biol. 2016 Feb 10. doi: 10.1111/adb.12372. [Epub ahead of print]

PMID:
26860734
7.

[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].

Auxéméry Y.

Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24. Review. French.

PMID:
23062450
8.

5-HTTLPR moderates the relation between changes in depressive and bulimic symptoms in adolescent girls: a longitudinal study.

Mata J, Gotlib IH.

Int J Eat Disord. 2011 Jul;44(5):383-8. doi: 10.1002/eat.20850. Epub 2010 Nov 5.

PMID:
21661000
9.

Emotional eating in adolescents: a gene (SLC6A4/5-HTT) - depressive feelings interaction analysis.

van Strien T, van der Zwaluw CS, Engels RC.

J Psychiatr Res. 2010 Nov;44(15):1035-42. doi: 10.1016/j.jpsychires.2010.03.012. Epub 2010 Apr 22.

PMID:
20416884
10.

Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study.

Fergusson DM, Horwood LJ, Miller AL, Kennedy MA.

Br J Psychiatry. 2011 Feb;198(2):129-35. doi: 10.1192/bjp.bp.110.085993.

11.

Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression.

Conway CC, Hammen C, Brennan PA, Lind PA, Najman JM.

Depress Anxiety. 2010 Aug;27(8):737-45. doi: 10.1002/da.20715.

12.

No interaction between serotonin transporter gene (5-HTTLPR) polymorphism and adversity on depression among Japanese children and adolescents.

Tomoda A, Nishitani S, Matsuura N, Fujisawa TX, Kawatani J, Toyohisa D, Ono M, Shinohara K.

BMC Psychiatry. 2013 May 10;13:134. doi: 10.1186/1471-244X-13-134.

13.

Chronic family stress interacts with 5-HTTLPR to predict prospective depressive symptoms among youth.

Jenness JL, Hankin BL, Abela JR, Young JF, Smolen A.

Depress Anxiety. 2011 Dec 21;28(12):1074-80. doi: 10.1002/da.20904. Epub 2011 Nov 4.

14.

Children's inferential styles, 5-HTTLPR genotype, and maternal expressed emotion-criticism: An integrated model for the intergenerational transmission of depression.

Gibb BE, Uhrlass DJ, Grassia M, Benas JS, McGeary J.

J Abnorm Psychol. 2009 Nov;118(4):734-45. doi: 10.1037/a0016765.

15.

Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.

Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, Fenske K, Barnow S, Freyberger HJ, Teumer A, Petersmann A, Biffar R, Rosskopf D, John U, Völzke H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):264-70. doi: 10.1016/j.pnpbp.2011.09.010. Epub 2011 Oct 2.

PMID:
21996278
16.

BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.

Buchmann AF, Hellweg R, Rietschel M, Treutlein J, Witt SH, Zimmermann US, Schmidt MH, Esser G, Banaschewski T, Laucht M, Deuschle M.

Eur Neuropsychopharmacol. 2013 Aug;23(8):902-9. doi: 10.1016/j.euroneuro.2012.09.003. Epub 2012 Oct 9.

PMID:
23058261
17.

Genetic susceptibility to family environment: BDNF Val66met and 5-HTTLPR influence depressive symptoms.

Dalton ED, Hammen CL, Najman JM, Brennan PA.

J Fam Psychol. 2014 Dec;28(6):947-56. doi: 10.1037/fam0000032. Epub 2014 Oct 27.

PMID:
25347540
18.

Differential susceptibility in longitudinal models of gene-environment interaction for adolescent depression.

Li JJ, Berk MS, Lee SS.

Dev Psychopathol. 2013 Nov;25(4 Pt 1):991-1003. doi: 10.1017/S0954579413000321.

PMID:
24229544
19.

The interplay between parental monitoring and the dopamine D4 receptor gene in adolescent cannabis use.

Otten R, Barker ED, Huizink AC, Engels RC.

PLoS One. 2012;7(11):e49432. doi: 10.1371/journal.pone.0049432. Epub 2012 Nov 28.

20.

Three-way interaction effect of 5-HTTLPR, BDNF Val66Met, and childhood adversity on depression: a replication study.

Comasco E, Åslund C, Oreland L, Nilsson KW.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1300-6. doi: 10.1016/j.euroneuro.2013.01.010. Epub 2013 Mar 6.

PMID:
23481907
Items per page

Supplemental Content

Write to the Help Desk